Thrombosis and Haemostasis, Table of Contents Thromb Haemost 1995; 74(01): 440-443DOI: 10.1055/s-0038-1642718 Symposium Management of Haemophilias Schattauer GmbH Stuttgart Some Aspects on the Management of Hemophilia Authors Author Affiliations Louis M Aledort The Mary Weinfield Professor of Clinical Research in Hemophilia, Mount Sinai School of Medicine, New York, NY, USA Recommend Article Abstract PDF Download(opens in new window) Buy Article(opens in new window) PDF (317 kb) References References 1 Kemoff P. Current Factor VIII Usage Related to Self Sufficiency: A European Overview. Factor VIII: Purity and Prophylaxis Royal Society of Medicine Services 1991; Roundtable Series No. 25: 4 2 Pettersson H, Gilbert M. Musculoskeletal and other haemorrhagic complications. In Diagnostic Imaging in Hemophilia Berlin: Springer-Verlag; 1985: 55-60 3 Aledort LM, Haschmeyer RH, Pettersson H. The Orthopaedic Outcome Study Group. A longitudinal study of orthopaedic outcomes for severe factor-VUI-deficient haemophiliacs Journal of Internal Medicine 1994; 236: 391-399 4 Nilsson IM, Bemtorp E, Löfqvist T, Pettersson H. Twenty-five years’ experience of prophylactic treatment in severe haemophilia A and B. Journal of Internal Medicine 1992; 232: 25-32 5 Mannucci PM, Ruggeri ZM, Pareti FI, Capitano A. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrand’s disease. Lancet 1977; 1: 869-872 6 Mannucci PM. Desmopressin (DDAVP) for treatment of disorders of hemostasis. In: Coller BS. (ed) Progress in hemostasis and thrombosis. Gnine and Stratton. Orlando,FL: 1986: 19-45 7 Lethargen S, Harris AS, Sjörin E, Nilsson IM. Intranasal and intravenous administration of desmopression: Effect on FVIII/FWF, pharmacokenetics and reproducibility. Thromb Haemost 1987; 58: 1033-1036 8 Rose EH, Aledort LM. Nasal Spray Desmopressin (DDAVP) for Mild hemophilia A and von Willebrand disease. Annals Internal Medicine 1991; 114: 563-568 9 Seremetis SV, Aledort LM. Nasal Spray desmopressin (DDAVP) experience in home care and surgical prophylaxis. In Abstracts 7 the XXI International Congress of the World Federation of Hemophilia Abstract 206 24-29 04/1994. Mexico City, Mexico: 10 Christolini A, Drogoni F, Ferrari A, LaVerde G, Avcieri R, Mohamud AE, Mazzucconi MG. Intranasal DDAVP Biological and clinical evaluation in mild factor VIII deficiency. Haemostasis 1991; 21: 273-277
